CD79b targeting ADC with superior pharmacokinetic profile and anti-tumor activity.

被引：0

作者：

Spycher, Philipp Rene ^{[1
]}

Probst, Philipp ^{[1
]}

Bertrand, Romain ^{[1
]}

Stark, Ramona ^{[1
]}

Santimaria, Roger ^{[1
]}

Grabulovski, Dragan ^{[1
]}

Attinger-Toller, Isabella ^{[1
]}

机构：

[1] Araris Biotech AG, Zurich, Switzerland

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1842

引用

页数：1

共 50 条

[31] Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79b [J].

Seon, Ben K. ;

Okazaki, Morihiro ;

Duzen, Jill ;

Matsuno, Fumihiko ;

Goey, Andrew K. L. ;

Maguire, Orla .

LEUKEMIA RESEARCH, 2024, 136

[32] Absolute configuration and anti-tumor activity of torrubiellin B [J].

Hemphill, Catalina Francis Perez ;

Daletos, Georgios ;

Hamacher, Alexandra ;

Kassack, Matthias Ullrich ;

Lin, Wenhan ;

Mandi, Attila ;

Kurtan, Tibor ;

Proksch, Peter .

TETRAHEDRON LETTERS, 2015, 56 (30) :4430-4433

[33] Synthesis and anti-tumor activity of Fissitungfine B compounds [J].

Zhou, Shiyang ;

Zhou, Xiaofeng ;

Huang, Gangliang .

CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (03) :305-312

[34] DXC006, Anti-CD56-CPT113 ADC displays favorable anti-tumor efficacy, pharmacokinetic and safety profiles in preclinical studies [J].

Kong, Xiangfei ;

Guo, Huihui ;

Du, Yong ;

Ye, Zhicang ;

Chen, Yongxiang ;

Guo, Zhixiang ;

Zhang, Lingli ;

Bai, Lu ;

Jia, Junxiang ;

Zheng, Yunxia ;

Zheng, Wei ;

Zheng, Jun ;

Li, Wenjun ;

Huang, Yuanyuan ;

Fan, Zhongliang ;

Liu, Mengmeng ;

Chen, Binbin ;

Dai, Meng ;

Wang, Juan ;

Du, Fang ;

Chen, Miaomiao ;

Yang, Qingliang ;

Zhao, Robert Y. .

CANCER RESEARCH, 2024, 84 (06)

[35] Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma [J].

Sun, Bao-Ye ;

Zhang, Dai ;

Gan, Wei ;

Wu, Jing-Fang ;

Wang, Zhu-Tao ;

Sun, Guo-Qiang ;

Zhou, Jian ;

Fan, Jia ;

Yi, Yong ;

Hu, Bo ;

Zhang, Bo-Heng ;

Qiu, Shuang-Jian .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (07)

[36] RESET: A Novel TCR Coupled Antigen Receptor Displaying Superior Targeting Sensitivity and Pharmacologically Controlled Anti-Tumor Activity [J].

Leleux, Jardin A. ;

Sonzogni, Olmo ;

Rosenberg, Jill ;

McGinty, Jack ;

Venkitaraman, Anita ;

Jarjour, Jordan .

MOLECULAR THERAPY, 2023, 31 (04) :305-305

[37] A BISPECIFIC ANTIBODY TARGETING CD40 AND EPCAM INDUCES SUPERIOR ANTI-TUMOR EFFECTS COMPARED TO THE COMBINATION OF THE MONOSPECIFIC ANTIBODIES [J].

Ellmark, Peter ;

Hagerbrand, Karin ;

Levin, Mattias ;

Von Schantz, Laura ;

Deronic, Adnan ;

Varas, Laura ;

Sall, Anna ;

Barchan, Karin ;

Werchau, Doreen ;

Ljug, Lill ;

Thageson, Mia ;

Rosen, Anna ;

Sakellariou, Christina ;

Lindstedt, Malin ;

Ellmark, Peter .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 :A511-A511

[38] Orally available, synthetic Hsp90 inhibitors have anti-tumor activity. [J].

Lundgren, K ;

Lough, R ;

Huser, N ;

Brekken, J ;

Kamal, A ;

Sensintaffer, J ;

Yang, YC ;

Zhang, H ;

Timony, G ;

Hong, K ;

Kasibhatla, S ;

Boehm, M ;

Burrows, F .

CLINICAL CANCER RESEARCH, 2005, 11 (24) :9087S-9087S

[39] Targeting PVR (CD155) and its receptors in anti-tumor therapy [J].

Paola Kučan Brlić ;

Tihana Lenac Roviš ;

Guy Cinamon ;

Pini Tsukerman ;

Ofer Mandelboim ;

Stipan Jonjić .

Cellular & Molecular Immunology, 2019, 16 :40-52

[40] Targeting PVR (CD155) and its receptors in anti-tumor therapy [J].

Brlic, Paola Kucan ;

Rovis, Tihana Lenac ;

Cinamon, Guy ;

Tsukerman, Pini ;

Mandelboim, Ofer ;

Jonjic, Stipan .

CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (01) :40-52

← 1 2 3 4 5 →